The Hippo size control pathway - Ever expanding

Science Signaling

Volumn 6, Issue 259, 2013, Pages

  Lin, Jane I ^a,b   Poon, Carole L C ^a,b   Harvey, Kieran F ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROTEIN TYROSINE PHOSPHATASE 14; REGULATOR PROTEIN; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

CARCINOGENESIS; CELL FATE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DROSOPHILA; EPITHELIUM CELL; HIPPO PATHWAY; IN VIVO STUDY; MAMMAL CELL; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; CELL PROLIFERATION; CYTOSKELETAL PROTEINS; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EPITHELIAL CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

MAMMALIA;

EID: 84872690692     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003813     Document Type: Review

References (31)

1. N. Tapon, K. F. Harvey, D. W. Bell, D. C. Wahrer, T. A. Schiripo, D. A. Haber, I. K. Hariharan, salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110, 467-478 (2002).
2. K. Harvey, N. Tapon, The Salvador-Warts-Hippo pathway - An emerging tumour-suppressor network. Nat. Rev. Cancer 7, 182-191 (2007).
3. G. Halder, R. L. Johnson, Hippo signaling: Growth control and beyond. Development 138, 9-22 (2011).
4. D. Pan, Hippo signaling in organ size control. Genes Dev. 21, 886-897 (2007).
5. K. F. Harvey, I. K. Hariharan, The hippo pathway. Cold Spring Harb. Perspect. Biol. 4, a011288 (2012).
6. J. Avruch, D. Zhou, J. Fitamant, N. Bardeesy, F. Mou, L. R. Barrufet, Protein kinases of the Hippo pathway: Regulation and substrates. Semin. Cell Dev. Biol. 23, 770-784 (2012).
7. I. Poernbacher, R. Baumgartner, S. K. Marada, K. Edwards, H. Stocker, Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation. Curr. Biol. 22, 389-396 (2012).
8. W. Wang, J. Huang, X. Wang, J. Yuan, X. Li, L. Feng, J. I. Park, J. Chen, PTPN14 is required for the density-dependent control of YAP1. Genes Dev. 26, 1959-1971 (2012).
9. X. Liu, N. Yang, S. A. Figel, K. E. Wilson, C. D. Morrison, I. H. Gelman, J. Zhang, PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene 10.1038/onc.2012.147 (2012).
10. J. M. Huang, I. Nagatomo, E. Suzuki, T. Mizuno, T. Kumagai, A. Berezov, H. Zhang, B. Karlan, M. I. Greene, Q. Wang, YAP modifi es cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene 10.1038/onc.2012.231 (2012).
11. J. S. Mo, F. X. Yu, R. Gong, J. H. Brown, K. L. Guan, Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev. 26, 2138-2143 (2012).
12. M. Sudol, K. F. Harvey, Modularity in the Hippo signaling pathway. Trends Biochem. Sci. 35, 627-633 (2010).
13. B. Zhao, X. Wei, W. Li, R. S. Udan, Q. Yang, J. Kim, J. Xie, T. Ikenoue, J. Yu, L. Li, P. Zheng, K. Ye, A. Chinnaiyan, G. Halder, Z. C. Lai, K. L. Guan, Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761 (2007).
14. A. Genevet, M. C. Wehr, R. Brain, B. J. Thompson, N. Tapon, Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev. Cell 18, 300-308 (2010).
15. J. Yu, Y. Zheng, J. Dong, S. Klusza, W. M. Deng, D. Pan, Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev. Cell 18, 288-299 (2010).
16. R. Baumgartner, I. Poernbacher, N. Buser, E. Hafen, H. Stocker, The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev. Cell 18, 309-316 (2010).
17. S. W. Chan, C. J. Lim, C. Huang, Y. F. Chong, H. J. Gunaratne, K. A. Hogue, W. P. Blackstock, K. F. Harvey, W. Hong, WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. Oncogene 30, 600-610 (2011).
18. X. Zhang, C. C. Milton, C. L. Poon, W. Hong, K. F. Harvey, Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador-Warts-Hippo pathway. Cell Death Differ. 18, 1346-1355 (2011).
19. W. Hong, K. L. Guan, The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway. Semin. Cell Dev. Biol. 23, 785-793 (2012).
20. L. Sansores-Garcia, W. Bossuyt, K. Wada, S. Yonemura, C. Tao, H. Sasaki, G. Halder, Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 30, 2325-2335 (2011).
21. B. G. Fernández, P. Gaspar, C. Brás-Pereira, B. Jezowska, S. R. Rebelo, F. Janody, Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development 138, 2337-2346 (2011).
22. K. Wada, K. Itoga, T. Okano, S. Yonemura, H. Sasaki, Hippo pathway regulation by cell morphology and stress fi bers. Development 138, 3907-3914 (2011).
23. B. Zhao, L. Li, L. Wang, C. Y. Wang, J. Yu, K. L. Guan, Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 26, 54-68 (2012).
24. S. Dupont, L. Morsut, M. Aragona, E. Enzo, S. Giulitti, M. Cordenonsi, F. Zanconato, J. Le Digabel, M. Forcato, S. Bicciato, N. Elvassore, S. Piccolo, Role of YAP/TAZ in mechanotransduction. Nature 474, 179-183 (2011).
25. F. X. Yu, B. Zhao, N. Panupinthu, J. L. Jewell, I. Lian, L. H. Wang, J. Zhao, H. Yuan, K. Tumaneng, H. Li, X. D. Fu, G. B. Mills, K. L. Guan, Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780-791 (2012).
26. X. Yang, K. Yu, Y. Hao, D. M. Li, R. Stewart, K. L. Insogna, T. Xu, LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nat. Cell Biol. 6, 609-617 (2004).
27. R. M. Densham, E. O'Neill, J. Munro, I. König, K. Anderson, W. Kolch, M. F. Olson, MST kinases monitor actin cytoskeletal integrity and signal via c-Jun N-terminal kinase stress-activated kinase to regulate p21Waf1/Cip1 stability. Mol. Cell. Biol. 29, 6380-6390 (2009).
28. R. Kaufmann, S. Rahn, K. Pollrich, J. Hertel, Y. Dittmar, M. Hommann, P. Henklein, C. Biskup, M. Westermann, M. D. Hollenberg, U. Settmacher, Thrombin-mediated hepatocellular carcinoma cell migration: Cooperative action via proteinase-activated receptors 1 and 4. J. Cell. Physiol. 211, 699-707 (2007).
29. A. A. Steinhardt, M. F. Gayyed, A. P. Klein, J. Dong, A. Maitra, D. Pan, E. A. Montgomery, R. A. Anders, Expression of Yes-associated protein in common solid tumors. Hum. Pathol. 39, 1582-1589 (2008).
30. X. Zhang, J. George, S. Deb, J. L. Degoutin, E. A. Takano, S. B. Fox, D. D. Bowtell, K. F. Harvey, AOCS Study group, The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene 30, 2810-2822 (2011).
31. M. Z. Xu, T. J. Yao, N. P. Lee, I. O. Ng, Y. T. Chan, L. Zender, S. W. Lowe, R. T. Poon, J. M. Luk, Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115, 4576-4585 (2009).